Fundz

PlaqueTec secures $8M in equity financing led by Lord Moynihan of Chelsea and the Future Fund to support ongoing BIOPATTERN trial and develop BIOCARTA

PRIVATEApr 30, 2024

Amount Raised

$8 Million

Round Type

Venture

CambridgeBiotechnologyHealth CareMedical

Investors

Future FundLord Moynihan Of Chelsea

Description

PlaqueTec has secured $8 million in equity financing led by Lord Moynihan of Chelsea alongside the Future Fund, with support from existing investors. The funding will be used to support PlaqueTec’s ongoing BIOPATTERN trial, designed to improve understanding of CAD pathobiology and how it varies between individuals and to build BIOCARTA, its novel biomarker discovery tool.

Quick answer

PlaqueTec raised $8 Million in a funding round, dated April 30, 2024. Investors: Future Fund and Lord Moynihan Of Chelsea. PlaqueTec is based in Cambridge, England, United Kingdom.

How much did PlaqueTec raise?
PlaqueTec raised $8 Million in a funding round on April 30, 2024.
Who invested in PlaqueTec?
Future Fund and Lord Moynihan Of Chelsea are named as investors in this round.
What does PlaqueTec do?
PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine.
Where is PlaqueTec based and how big is it?
PlaqueTec is based in Cambridge, England, United Kingdom. Fundz records about 4 employees.
Who are the decision-makers at PlaqueTec?
Fundz holds 1 contact at PlaqueTec. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as PlaqueTec that raised within 45 days of this round, from Fundz verified event records.

  • Hubly raised $1.3M on June 14, 2024.
  • UPyTher raised $1.5M (Seed) on June 13, 2024.
  • i'SUPPLY raised $2.5M (Pre-Series A) on June 11, 2024.
  • Leo Cancer Care raised an undisclosed amount (Series C) on June 11, 2024.
  • Novocuff raised $6.8M on June 4, 2024.
  • Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.

Who to call at PlaqueTec, and when

A new round usually means PlaqueTec is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PlaqueTec raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PlaqueTec, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PlaqueTec. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PlaqueTec

Location

Cambridge, England, United Kingdom

About

PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine. CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression. A more detailed understanding of patient endotypes will support drug development by identifying new targets in specific patient groups, reducing clinical trial sizes and costs, and increasing success rates, ultimately improving outcomes for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PlaqueTec raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for PlaqueTec's next move

See what Strategic adds

PlaqueTec raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.